Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × selinexor × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 17 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 5 Sarcoma 3 Neurofibrosarcoma 3 Primary Myelofibrosis 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Glioblastoma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Vascular Neoplasms 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasms 1 Neoplasm Metastasis 1 Myoepithelioma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

Cyclophosphamide 11 blinatumomab 8 fludarabine 7 venetoclax 6 fludarabine phosphate 5 Cytarabine 5 Rituximab 4 Lenalidomide 4 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Radiotherapy 2 Methotrexate 2 Melphalan 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡